Ardian, Bregal Sagemount, Riverside and Thoma Bravo are among the PE dealmakers targeting the life sciences software market. Regulatory pressures and AI opportunities are driving interest.

Bregal Sagemount principal Harrison Brunelli said AI across pharmaceutical research and regulatory workflows creates a significant investment opportunity. Software for data traceability and compliance is particularly sought after.

PE Hub rounded up eight deals since March. Eir Partners acquired Accumulus Technologies, a cloud-based regulatory collaboration platform with 75+ authorities. "Accumulus occupies a unique position," said Brett Carlson, Eir founder and CEO.

Thoma Bravo took Kneat Solutions private for $466 million in August. The C$6.50 per share price was a 40% premium. Kneat Gx digitalizes validation and compliance data. "Kneat has established itself as a vital platform," said Chandler Gay, senior vice president.

Riverside-backed Decera Clinical invested in Onviv, a healthcare knowledge and expert network platform based in Morristown, New Jersey.